NCT05932381 (CDT) is a NA clinical trial of Complete decongestive therapy in Lymphedema, sponsored by Cairo University.

Who is sponsoring NCT05932381?

NCT05932381 is sponsored by Cairo University.

What drugs are being tested in NCT05932381?

Interventions in NCT05932381: Complete decongestive therapy, Medical treatment.

What condition does NCT05932381 study?

NCT05932381 studies Lymphedema.

Is NCT05932381 still recruiting?

NCT05932381 is currently status unknown. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05932381: CDT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect Of Complete Decongestive Therapy On Carpal Tunnel Syndrome Post Upper Limb Lymphedema

Status unknown NA Last updated 6 July 2023

What this trial tests

NA trial testing Complete decongestive therapy in Lymphedema in 60 participants. Status unknown.

Timeline

5 July 2023

Primary endpoint
5 October 2023

5 October 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	5 July 2023
Primary completion	5 October 2023
Estimated completion	5 October 2023

Drugs / interventions tested

Complete decongestive therapy
Medical treatment — full drug profile →

Conditions studied

Lymphedema — all drugs for Lymphedema →

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted to investigate the therapeutic effect of complete decongestive therapy on carpal tunnel syndrome post-upper limb lymphedema.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

NCT07489248 — Multimodal Ultrasound for Differentiating Lymphedema and Lipedema · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
NCT06866197 — CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05932381 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05932381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing